So far this year, three of the world’s safest blue chip stocks returned 58.5%, 85.2%, and 112.5%, but most investors weren’t even able to touch them. Today, I’ll show you how you can…

In February, I wrote that the decline in stocks was just about over. Why?

As investors plowed into financial and housing stocks in the last few years, they forgot about the pharmaceutical industry, says Jim Nelson in Penny Sleuth.

But now that the party is over, biotech stocks are coming back in a big way. According to mutual-fund research firm Lipper, two biotech funds were amongst the top five best-performing vehicles in July – a dramatic reversal from June when commodities funds were leading the charge.

Big Pharma is buying up promising biotech companies in an effort to boost profit margins. This creates great opportunities for investors, and it’ only just the beginning…